RECRUITING

Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a prospective interventional study examining the effect of ketorolac at doses of 15mg versus 30 mg for duration of analgesia in emergency department patients with suspected renal colic.

Official Title

Evaluation of the Effects of Ketorolac 15mg IV Versus 30mg IV on Duration of Analgesia in Patients Who Present to the Emergency Department With Renal Colic

Quick Facts

Study Start:2023-12-21
Study Completion:2026-02-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05776953

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult emergency department patients \< 65 years old
  2. * One or more of the following common ED chief complaints associated with the suspected diagnosis of renal colic. These chief complaints include but are not limited to: flank pain, back pain, abdominal pain, left and/or right lower quadrant pain, and/or pelvic pain
  3. * Pain score of 4 or greater on the 0-10 NRS
  4. * Determination of treatment with IV ketorolac
  1. * Allergy to ketorolac
  2. * Pregnant patients
  3. * Previously received analgesic medications within 4 hours prior to administration of ketorolac in our ED
  4. * Known or stated history of renal insufficiency
  5. * Body weight \< 50 kg
  6. * Age greater than 65 years
  7. * Patients that do no read/write Spanish or English

Contacts and Locations

Study Contact

Biren Bhatt, MD
CONTACT
551-996-2000
biren.bhatt@hmhn.org

Principal Investigator

Biren Bhatt, MD
PRINCIPAL_INVESTIGATOR
Hackensack Meridian Health

Study Locations (Sites)

Hackensack Univarsity medical Center
Hackensack, New Jersey, 07601
United States

Collaborators and Investigators

Sponsor: Hackensack Meridian Health

  • Biren Bhatt, MD, PRINCIPAL_INVESTIGATOR, Hackensack Meridian Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-12-21
Study Completion Date2026-02-28

Study Record Updates

Study Start Date2023-12-21
Study Completion Date2026-02-28

Terms related to this study

Additional Relevant MeSH Terms

  • Renal Colic
  • Flank Pain
  • Emergencies
  • Analgesia